These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20659584)

  • 21. DNA damage induced by alloisoleucine and other metabolites in maple syrup urine disease and protective effect of l-carnitine.
    Hauschild TC; Guerreiro G; Mescka CP; Coelho DM; Steffens L; Moura DJ; Manfredini V; Vargas CR
    Toxicol In Vitro; 2019 Jun; 57():194-202. PubMed ID: 30853490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of redox homeostasis and brain damage caused in vivo by methylmalonic acid and ammonia in cerebral cortex and striatum of developing rats.
    Viegas CM; Zanatta Â; Grings M; Hickmann FH; Monteiro WO; Soares LE; Sitta Â; Leipnitz G; de Oliveira FH; Wajner M
    Free Radic Res; 2014 Jun; 48(6):659-69. PubMed ID: 24580146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylmalonic acid administration induces DNA damage in rat brain and kidney.
    Andrade VM; Dal Pont HS; Leffa DD; Damiani AP; Scaini G; Hainzenreder G; Streck EL; Ferreira GC; Schuck PF
    Mol Cell Biochem; 2014 Jun; 391(1-2):137-45. PubMed ID: 24532006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixture.
    Touati G; Valayannopoulos V; Mention K; de Lonlay P; Jouvet P; Depondt E; Assoun M; Souberbielle JC; Rabier D; Ogier de Baulny H; Saudubray JM
    J Inherit Metab Dis; 2006; 29(2-3):288-98. PubMed ID: 16763890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sources of propionate in inborn errors of propionate metabolism.
    Thompson GN; Walter JH; Bresson JL; Ford GC; Lyonnet SL; Chalmers RA; Saudubray JM; Leonard JV; Halliday D
    Metabolism; 1990 Nov; 39(11):1133-7. PubMed ID: 2233273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute and chronic administration of methylmalonic and propionic acids on the in vitro incorporation of 32P into cytoskeletal proteins from cerebral cortex of young rats.
    de Mattos-Dutra A; de Freitas MS; Lisboa CS; Pessoa-Pureur R; Wajner M
    Neurochem Int; 1998 Jul; 33(1):75-82. PubMed ID: 9694045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Outcomes of patients with combined methylmalonic acidemia and homocystinuria after treatment].
    Huang Z; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Ji WJ; Li XY; Gu XF
    Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):194-8. PubMed ID: 23751581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding acute metabolic decompensation in propionic and methylmalonic acidemias: a deep metabolic phenotyping approach.
    Haijes HA; Jans JJM; van der Ham M; van Hasselt PM; Verhoeven-Duif NM
    Orphanet J Rare Dis; 2020 Mar; 15(1):68. PubMed ID: 32143654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergency presentations of patients with methylmalonic acidemia, propionic acidemia and branched chain amino acidemia (MSUD).
    Henriquez H; el Din A; Ozand PT; Subramanyam SB; al Gain SI
    Brain Dev; 1994 Nov; 16 Suppl():86-93. PubMed ID: 7726386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial.
    Alfadhel M; Nashabat M; Saleh M; Elamin M; Alfares A; Al Othaim A; Umair M; Ahmed H; Ababneh F; Al Mutairi F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Almannai M; Aljeraisy M; Albdah B; Hussein MA; Rahbeeni Z; Alasmari A
    Orphanet J Rare Dis; 2021 Oct; 16(1):422. PubMed ID: 34635114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylmalonic and propionic aciduria.
    Deodato F; Boenzi S; Santorelli FM; Dionisi-Vici C
    Am J Med Genet C Semin Med Genet; 2006 May; 142C(2):104-12. PubMed ID: 16602092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic administration of methylmalonate on young rats alters neuroinflammatory markers and spatial memory.
    Ribeiro LR; Della-Pace ID; de Oliveira Ferreira AP; Funck VR; Pinton S; Bobinski F; de Oliveira CV; da Silva Fiorin F; Duarte MM; Furian AF; Oliveira MS; Nogueira CW; Dos Santos AR; Royes LF; Fighera MR
    Immunobiology; 2013 Sep; 218(9):1175-83. PubMed ID: 23726524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Abnormal findings during newborn period of 160 patients with early-onset methylmalonic aciduria].
    Liu YP; Ma YY; Wu TF; Wang Q; Li XY; Ding Y; Song JQ; Huang Y; Yang YL
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):410-4. PubMed ID: 22931934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy of metabolic disorders with intravenous (IV) access ports and long term intravenous L-carnitine therapy.
    Winter S; Birek L; Walker T; Phalin-Roque J; Chandler MJ; Field C; Zorn E
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():152-3. PubMed ID: 11400757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical studies on fifty-seven Chinese patients with combined methylmalonic aciduria and homocysteinemia].
    Zhang Y; Song JQ; Liu P; Yan R; Dong JH; Yang YL; Wang LF; Jiang YW; Zhang YH; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):513-7. PubMed ID: 17953808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of propionic and methylmalonic acids on the in vitro phosphorylation of intermediate filaments from cerebral cortex of rats during development.
    de Almeida LM; Funchal C; Pelaez Pde L; Pessutto FD; Loureiro SO; Vivian L; Wajner M; Pessoa-Pureur R
    Metab Brain Dis; 2003 Sep; 18(3):207-19. PubMed ID: 14567471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of metronidazole in management of methylmalonic and propionic acidaemias.
    Thompson GN; Chalmers RA; Walter JH; Bresson JL; Lyonnet SL; Reed PJ; Saudubray JM; Leonard JV; Halliday D
    Eur J Pediatr; 1990 Aug; 149(11):792-6. PubMed ID: 2226555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics identifies perturbations in human disorders of propionate metabolism.
    Wikoff WR; Gangoiti JA; Barshop BA; Siuzdak G
    Clin Chem; 2007 Dec; 53(12):2169-76. PubMed ID: 17951291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propionylcarnitine excretion is not affected by metronidazole administration to patients with disorders of propionate metabolism.
    Burns SP; Iles RA; Saudubray JM; Chalmers RA
    Eur J Pediatr; 1996 Jan; 155(1):31-5. PubMed ID: 8750807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carnitine in the treatment of methylmalonic aciduria (MMA)].
    Penn D; Schmidt H; Otten A; Schmidt-Sommerfeld E
    Monatsschr Kinderheilkd; 1986 Oct; 134(10):758-61. PubMed ID: 2879226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.